Nicotine Lozenge to Reduce Smokeless Tobacco Use

NCT00218283 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

NIH

Sponsor class

Conditions

Tobacco Use Disorder

Interventions

DRUG: Nicotine Lozenge
BEHAVIORAL: Behavioral Counseling

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators

[object Object]